Johnson & Johnson (NEO:JNJ)

Market Cap	603.46B
Revenue (ttm)	123.77B
Net Income (ttm)	30.95B
Shares Out	n/a
EPS (ttm)	12.75
PE Ratio	19.50
Forward PE	16.45
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,110
Average Volume	6,466
Open	23.35
Previous Close	23.15
Day's Range	23.19 - 23.48
52-Week Range	18.75 - 23.65
Beta	0.52
RSI	61.07
Earnings Date	Oct 14, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Cboe Canada
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD